Relmada Therapeutics Inc

NASDAQ RLMD

Data sourced from iex and EODHD
Download Data

Relmada Therapeutics Inc Income Statement 2011 - 2024

This table shows the Income Statement for Relmada Therapeutics Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0
Gross Profit
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M - - - - - - - - - - - - - - - - - - - - - 3 2 2 3 1 1 2 2 2 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0
Selling, General, and Administrative Expenses (SG&A)
M 10 12 12 12 12 12 8 15 13 9 9 9 8 6 6 7 5 3 2 1 1 2 1 1 1 1 1 2 2 1 1 2 2 4 2 2 2 2 3 3 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 13 15 10 14 16 27 31 31 25 25 34 17 14 15 11 5 5 2 2 3 1 1 1 1 2 0 0 0 0 0 0 1 1 2 3 3 2 2 1 1 1 0 - - - - - - - -
Other Operating Expenses
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -1 0 - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - 3 2 2 3 1 1 2 2 2 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0
Operating Income
M -23 -27 -23 -26 -28 -39 -39 -46 -38 -34 -43 -26 -22 -21 -17 -13 -10 -5 -4 -4 -3 -3 -2 -2 -3 -1 -1 -2 -2 -2 -2 -3 -3 -6 -5 -4 -5 -4 -4 -4 0 0 0 0 0 0 0 0 0 0
Interest Expense
M - - - 1 2 1 1 6 1 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 16 7 - - - - - - - -
Non-operating Income/Expense
M 1 2 -1 -1 1 0 -1 6 -1 0 0 0 0 0 0 1 -1 0 0 0 0 -4 0 -1 0 0 0 0 0 1 0 0 1 3 9 10 2 10 -26 -26 16 -7 - - - - - - - 0
EBT
M -22 -25 -22 -25 -26 -38 -39 -40 -40 -34 -43 -27 -22 -21 -17 -11 -11 -5 -4 -4 -3 -7 -3 -3 -3 -1 -1 -2 -2 -1 -2 -3 -2 -2 5 6 -2 5 -30 -30 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M -23 0 -1 -1 -1 -1 1 -6 1 0 0 0 0 0 0 -2 1 - - 4 - 4 1 1 1 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 - - - - - - - - - - 0
Income after Tax
M 1 -25 -21 -24 -25 -37 -40 -34 -41 -35 -42 -27 -22 -21 -17 -9 -11 - - -8 - -11 -4 -5 -4 -1 -1 -2 -2 -1 -2 -4 -1 -2 5 6 -2 5 -30 - - - - - - - - - - 0
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - - 0 0 0 - 0 0 0 - 0 - - - -
Net Income
M - - - -25 -26 -38 -39 -40 -40 -34 -43 -27 -22 -21 -17 -11 -11 -5 -4 -4 -3 -7 -3 -3 -3 -1 -1 -2 -2 -1 -2 - -2 -2 5 - 6 -2 5 -30 - 0 0 0 - 0 - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 30,132,170.00 30,099,203.00 30,099,203.00 30,099,203.00 30,099,203.00 29,628,664.00 30,063,735.00 29,935,895.00 28,392,601.00 17,552,738.00 17,478,477.00 17,054,646.00 16,572,672.00 15,594,228.00 16,044,670.00 15,323,051.00 14,738,230.00 6,311,768.00 9,761,188.00 9,761,188.00 7,509,492.00 6,395,980.00 3,137,468.00 3,137,467.00 3,136,905.00 3,136,794.00 3,133,210.00 3,133,210.00 3,008,978.00 3,008,978.00 3,008,833.00 3,008,833.00 3,000,947.00 2,855,044.00 3,234,346.00 2,684,832.00 2,684,832.00 3,521,851.00 2,036,357.00 2,036,357.00 1,425,000.00 1,425,000.00 1,425,000.00 1,175,000.00 1,175,000.00 1,175,000.00 1,175,000.00 705,163.00 705,163.00 700,000.00
EBITDA
M -23 -27 -22 -25 -29 -38 -37 -44 -37 -34 -42 -26 -22 -21 -17 -14 -9 -5 -4 0 -3 0 -2 -1 -2 -2 -1 -2 -3 -2 -2 -3 -4 -6 -5 -4 -5 -4 -4 -30 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 23 0 1 1 -1 0 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - 0
EBIT
M -46 -27 -23 -26 -28 -39 -39 -46 -38 -34 -43 -26 -22 -21 -17 -14 -9 -5 -4 0 -3 0 -2 -1 -2 -2 -1 -2 -3 -2 -2 -3 -4 -6 -5 -4 -5 -4 -4 -30 0 0 0 0 - 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 105.31 0.11 6.01 5.39 4.59 2.94 -1.73 13.97 -3.64 -0.57 0.70 -0.34 0.86 0.78 1.66 14.74 -6.55 - - -92.88 - -51.20 -19.24 -42.38 -20.36 2.05 -0.32 6.35 12.34 43.52 -4.93 -10.41 47.71 -0.05 0.04 0.01 -0.01 0.02 -0.01 - - - - - - - - - - 74.95
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 0 0 - 0 0 0 - 0 - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.44 8.86 8.86 49.21 20.55 20.55 13.91 34.13 27.00 25.17
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -776.97 -668.32 -3,073.34 -176.73 -176.73 -419.73 -569.57 -620.25 -8.35
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -168.86 -776.97 -3,073.34 - -176.73 - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -436.07 -768.86 -660.22 -3,073.34 -176.73 -176.73 -419.73 -569.57 -620.25 4.17
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -776.97 -668.32 -1,950.16 - -176.73 -419.73 -569.57 -620.25 -8.35
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -776.97 -668.32 -3,073.34 -176.73 -176.73 -419.73 -569.57 -620.25 -8.35

StockViz Staff

September 19, 2024

Any question? Send us an email